Takashi Shigematsu

Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder

Masafumi Fukagawa, Keitaro Yokoyama, Fumihiko Koiwa et al. · Therapeutic Apheresis and Dialysis · 2013 · 382 citations · Full text

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency

Takashi Shigematsu, Junichiro James Kazama, Takeyoshi Yamashita et al. · American Journal of Kidney Diseases · 2004 · 325 citations

Possible Involvement, Secondary Hyperparathyroidism, Urology +10

Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD

Masaaki Nakayama, Yoshindo Kawaguchi, Kenichi Yamada et al. · Kidney International · 1997 · 316 citations · Full text

Immunohistochemical Detection, Advanced Glycosylation End-products, Immunocytochemical Technique +12

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)

Shigeru Nakai, Kazuyuki Suzuki, Ikuto Masakane et al. · Therapeutic Apheresis and Dialysis · 2010 · 228 citations

Dialysis, Renal Pathology, December 2008 +24

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients

Shohei Nakanishi, Junichiro James Kazama, Tomoko Nii‐Kono et al. · Kidney International · 2005 · 208 citations

Hemodialysis, Urology, Renal Function +12